North America Advanced Wound Care Market Report: Market Size & Forecast 2026

The North America Advanced Wound Care Market encompasses advanced dressings such as hydrogels, foams, films, and collagen matrices, along with bioactive skin substitutes, negative pressure wound therapy devices, and adjunctive technologies. Spending is concentrated in the United States, where Medicare and private insurers reimburse a large share of chronic wound treatment, with Canada contributing additional demand. North America holds about 40 percent of the global advanced wound care market, the largest regional share, on the back of well-developed hospital infrastructure and high procedural volumes.

• •Estimated 2025 market value: approximately $13.55 billion for North America
• •Projected compound annual growth rate: 5.12 percent per year
• •Region accounts for roughly 40 percent of global advanced wound care revenue

Rising prevalence of diabetic foot ulcers, pressure injuries, venous leg ulcers, and post-surgical wounds is driving sustained procedure volume across inpatient and outpatient settings. Demographic aging, higher rates of obesity, and longer life expectancy are expanding the pool of patients with hard-to-heal wounds. Favorable reimbursement for advanced products in the United States and increasing clinical evidence supporting biologics and collagen-based dressings continue to pull new therapies into routine practice.

• •Diabetes and obesity are key clinical risk factors increasing chronic wound incidence
• •Aging population in the U.S. and Canada is enlarging the at-risk patient base
• •Reimbursement coverage for advanced dressings and biologics supports adoption

By product, hydrogels, foam dressings, films, hydrocolloids, alginates, collagen dressings, antimicrobial dressings, skin substitutes and grafts, and negative pressure wound therapy devices form the core categories, with hydrogel dressings expanding at roughly 5.5 percent CAGR between 2025 and 2032. End users include hospitals, specialty wound care clinics, long-term care facilities, and home-health settings, with hospitals historically representing the largest share of revenue. Within North America, the United States is the dominant market, while Canada is growing steadily through expanded community care and home-health programs.

• •Hydrogel dressings are among the fastest-growing product segments
• •Hospitals remain the largest end-user, with home health rising quickly in the U.S.
• •The United States accounts for the majority of North American market value

What are the recent trends and outlook?

Adoption of bioengineered skin substitutes, antimicrobial and collagen-based dressings, and adjunctive technologies such as cold plasma and photodynamic therapy is reshaping clinical protocols. Digital wound assessment tools and hospital-to-home care models are shortening inpatient stays and shifting volume toward outpatient and home-health settings. Based on current growth rates, the North America Advanced Wound Care Market is on track to exceed $18 billion by the early 2030s, supported by demographic demand and ongoing product innovation.

• •Biologics, antimicrobial dressings, and light- or plasma-based adjunctive therapies are gaining clinical traction
• •Digital wound imaging and remote monitoring support the shift to outpatient and home-based care
• •The market is projected to surpass $18 billion in North America within the next decade